Search company, investor...

Predict your next investment

Crohn's & Colitis Foundation company logo
Non-Profit Foundation
HEALTHCARE
crohnscolitisfoundation.org

See what CB Insights has to offer

Investments

1

Partners & Customers

10

About Crohn's & Colitis Foundation

Crohn's & Colitis Foundation aims to cure Crohn's disease and ulcerative colitis and to improve the quality of life of children and adults affected by these diseases. It also offers a range of educational programs for patients and healthcare professionals, while providing supportive services to help people cope with these chronic intestinal diseases.

Headquarters Location

733 Third Avenue Suite 510

New York, New York, 10017,

United States

800-932-2423

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Crohn's & Colitis Foundation Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Crohn's & Colitis Foundation Rank

Crohn's & Colitis Foundation Investments

1 Investments

Crohn's & Colitis Foundation has made 1 investments. Their latest investment was in TISSIUM as part of their Grant - II on February 2, 2020.

CBI Logo

Crohn's & Colitis Foundation Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/11/2020

Grant - II

TISSIUM

Yes

1

Date

2/11/2020

Round

Grant - II

Company

TISSIUM

Amount

New?

Yes

Co-Investors

Sources

1

Crohn's & Colitis Foundation Partners & Customers

10 Partners and customers

Crohn's & Colitis Foundation has 10 strategic partners and customers. Crohn's & Colitis Foundation recently partnered with Inotrem on April 4, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

4/14/2022

Partner

France

Paris (France), April 14th 2022. Inotrem and the Crohn’s & Colitis Foundation sign a R&D collaboration agreement to support the development of a new therapeutic approach in Inflammatory Bowel Disease (IBD) - Inotrem

Inotrem and the Crohn 's & Colitis Foundation sign a R&D collaboration agreement to support the development of a new therapeutic approach in Inflammatory Bowel Disease .

1

1/12/2022

Partner

United States

Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response

NEW YORK - -- Coral Genomics said on Wednesday that it has partnered with the Crohn 's & Colitis Foundation on a study of inflammatory bowel disease .

2

9/22/2021

Licensee

United States

Iterative Scopes and Crohn's & Colitis Foundation Announce Partnership to Advance Next-Generation IBD Treatment

The partnership gives Iterative Scopes rights to access IBD Plexus ® , the Foundation 's first-of-its-kind research information exchange platform , for the purpose of delivering artificial intelligence-driven endoscopic solutions to life sciences researchers and healthcare providers .

1

9/22/2021

Licensee

United States

Subscribe to see more

Subscribe to see more

10

7/6/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

4/14/2022

1/12/2022

9/22/2021

9/22/2021

7/6/2021

Type

Partner

Partner

Licensee

Licensee

Partner

Business Partner

Country

France

United States

United States

United States

United States

News Snippet

Paris (France), April 14th 2022. Inotrem and the Crohn’s & Colitis Foundation sign a R&D collaboration agreement to support the development of a new therapeutic approach in Inflammatory Bowel Disease (IBD) - Inotrem

Inotrem and the Crohn 's & Colitis Foundation sign a R&D collaboration agreement to support the development of a new therapeutic approach in Inflammatory Bowel Disease .

Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response

NEW YORK - -- Coral Genomics said on Wednesday that it has partnered with the Crohn 's & Colitis Foundation on a study of inflammatory bowel disease .

Iterative Scopes and Crohn's & Colitis Foundation Announce Partnership to Advance Next-Generation IBD Treatment

The partnership gives Iterative Scopes rights to access IBD Plexus ® , the Foundation 's first-of-its-kind research information exchange platform , for the purpose of delivering artificial intelligence-driven endoscopic solutions to life sciences researchers and healthcare providers .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.